Cargando…

Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review

INTRODUCTION: Xylazine, an α2-adrenoceptor agonist sedative commonly used in veterinary medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates have surged in recent years, fueled by an increasingly toxic and synthetic illicit drug supply in North America. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zhu, David T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498612/ https://www.ncbi.nlm.nih.gov/pubmed/37700329 http://dx.doi.org/10.1186/s12954-023-00867-x

Ejemplares similares

Xylazine-Involved Fatal and Nonfatal Drug Overdoses in Tennessee From 2019 to 2022
por: Korona-Bailey, Jessica, et al.
Publicado: (2023)

Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
por: Zagorski, Claire M., et al.
Publicado: (2023)

Correction: Reducing the harms of xylazine: clinical approaches, research deficits, and public health context
por: Zagorski, Claire M., et al.
Publicado: (2023)

“Tranq-Dope” Overdose and Mortality: Lethality Induced by Fentanyl and Xylazine
por: Smith, Mark A., et al.
Publicado: (2023)

“Tranq-dope” overdose and mortality: lethality induced by fentanyl and xylazine
por: Smith, Mark A., et al.
Publicado: (2023)

Notes from the Field: Xylazine Detection and Involvement in Drug Overdose Deaths — United States, 2019
por: Kariisa, Mbabazi, et al.
Publicado: (2021)

Xylazine in Drug Seizure Reports and Overdose Deaths in the US, 2018–2022
por: Cano, Manuel, et al.
Publicado: (2023)

Illicitly Manufactured Fentanyl–Involved Overdose Deaths with Detected Xylazine — United States, January 2019–June 2022
por: Kariisa, Mbabazi, et al.
Publicado: (2023)

Reducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction Strategies
por: Hawk, Kathryn F., et al.
Publicado: (2015)

Xylazine Use in Pregnancy: The Effects of the Fentanyl Adulterant Xylazine on Pregnant Patients and the Developing Fetus
por: Noonan, Grace, et al.
Publicado: (2023)

Virtual overdose monitoring services: a novel adjunctive harm reduction approach for addressing the overdose crisis
por: Matskiv, George, et al.
Publicado: (2022)

Editorial: Opioid overdose and harm reduction approaches to combat the looming crisis
por: Gunturu, Sasidhar, et al.
Publicado: (2023)

The New Stealth Drug on the Street: A Narrative Review of Xylazine as a Street Drug
por: Pergolizzi Jr, Joseph, et al.
Publicado: (2023)

An Exploration of Narcan as a Harm Reduction Strategy and User’s Attitudes toward Law Enforcement Involvement in Overdose Cases
por: Durieux, Jared, et al.
Publicado: (2022)

Drug use, homelessness and health: responding to the opioid overdose crisis with housing and harm reduction services
por: Milaney, Katrina, et al.
Publicado: (2021)

Potency-Enhancing Synthetics in the Drug Overdose Epidemic: Xylazine (“Tranq”), Fentanyl, Methamphetamine, and the Displacement of Heroin in Philadelphia and Tijuana
por: MONTERO, FERNANDO, et al.
Publicado: (2022)

Xylazine in the Opioid Epidemic: A Systematic Review of Case Reports and Clinical Implications
por: Ayub, Shahana, et al.
Publicado: (2023)

Clinical assessment of epidural analgesia induced by xylazine-lidocaine combination accompanied by xylazine sedation in calves
por: Kamiloglu, Alkan, et al.
Publicado: (2005)

Human Monkeypox: A Comprehensive Narrative Review and Analysis of the Public Health Implications
por: Di Gennaro, Francesco, et al.
Publicado: (2022)

Notes from the Field: Xylazine, a Veterinary Tranquilizer, Identified as an Emerging Novel Substance in Drug Overdose Deaths — Connecticut, 2019–2020
por: Thangada, Shobha, et al.
Publicado: (2021)

Comparison of cardiorespiratory and anesthetic effects of ketamine-midazolam-xylazine-sufentanil and tiletamine-zolazepam-xylazine in miniature pigs
por: Zhang, Zhiheng, et al.
Publicado: (2022)

Harm reduction in Asia and the Pacific: an evolving public health response
por: Crofts, Nick, et al.
Publicado: (2015)

Public health messaging and harm reduction in the time of COVID-19
por: Karamouzian, Mohammad, et al.
Publicado: (2020)

“We have to be uncomfortable and creative”: Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia
por: Aronowitz, Shoshana V., et al.
Publicado: (2021)

The Impact of Earthquakes on Public Health: A Narrative Review of Infectious Diseases in the Post-Disaster Period Aiming to Disaster Risk Reduction
por: Mavrouli, Maria, et al.
Publicado: (2023)

E-Cigarettes—a review of the evidence—harm versus harm reduction
por: Feeney, Susan, et al.
Publicado: (2022)

Pulverizing medication as a harm reduction and intentional drug overdose prevention strategy: Two case studies
por: Takanobu, Keisuke, et al.
Publicado: (2021)

Development of a digital platform to improve community response to overdose and prevention among harm reduction organizations
por: Claborn, Kasey, et al.
Publicado: (2022)

Harm reduction and recovery services support (HRRSS) to mitigate the opioid overdose epidemic in a rural community
por: Heo, Moonseong, et al.
Publicado: (2023)

Efficacy of caudal epidural injection of lidocaine, xylazine and xylazine plus hyaluronidase in reducing discomfort produced by electroejaculation in bulls
por: PAGLIOSA, Ronaldo C., et al.
Publicado: (2015)

Opportunities to Offer Harm Reduction to People who Inject Drugs During Infectious Disease Encounters: Narrative Review
por: Peckham, Alyssa M, et al.
Publicado: (2020)

Values associated with public involvement in health and social care research: a narrative review
por: Gradinger, Felix, et al.
Publicado: (2013)

Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Xylazine-induced reduction of tissue sensitivity to insulin leads to acute hyperglycemia in diabetic and normoglycemic monkeys
por: Xiao, Yong-Fu, et al.
Publicado: (2013)

A Case Report of a Novel Harm Reduction Intervention Used to Detect Opioid Overdose in the Emergency Department
por: Schreyer, Kraftin E., et al.
Publicado: (2020)

Ups and downs of addiction harm reduction in Iran: key insights and implications for harm reduction policy and policing
por: Shafiee, S. Ali, et al.
Publicado: (2023)

Immobilization of muskoxen (Ovibos moschatus) with etorphine and xylazine
por: Blix, Arnoldus Schytte, et al.
Publicado: (2011)

Xylazine (veterinary sedative) use in Puerto Rico
por: Torruella, Rafael A
Publicado: (2011)

Ketamine/Xylazine-Induced Corneal Damage in Mice
por: Koehn, Demelza, et al.
Publicado: (2015)

Intrathecal adenosine enhances the antinociception of Xylazine in goats
por: Abouelfetouh, Mahmoud M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_udi1qssvt60edqgfmivf7432t1